p38 mitogen-activated protein kinase is not activated in the quadriceps of patients with stable chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 2, 2012, Pages 142-150

  Riddoch Contreras, Joanna ^a   George, Tomasz ^a   Natanek, Samantha A ^b   Marsh, Gemma S ^b   Hopkinson, Nicholas S ^b   Tal Singer, Ruth ^c   Kemp, Paul ^a   Polkey, Michael I ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Chronic obstructive pulmonary disease (COPD); Mitogen activated protein kinase 14 (MAPK14); Muscle atrophy; Muscle wasting; P38 mitogen activated protein kinase; Skeletal muscle; Systemic inflammation

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN;

ACCELEROMETRY; ADIPOSE TISSUE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOCOMOTION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE STRENGTH; ONCOGENE C MYC; OUTPATIENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUADRICEPS FEMORIS MUSCLE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE WEAKNESS; MUSCULAR ATROPHY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84859314852     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.644359     Document Type: Article

References (53)

1. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010; 36(1):81-88.
2. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166(6):809-813.
3. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62(2):115-120.
4. Liu W, Liang Q, Balzar S, et al. Cell-specifi c activation profi le of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. J Allergy Clin Immunol 2008; 121(4):893-902 e2.
5. Renda T, Baraldo S, Pelaia G, et al. Increased activation of p38MAPK in COPD. Eur Respir J 2008; 31(1):62-69
6. Liu Q, Xu WG, Luo Y, et al. Cigarette smoke-induced skeletal muscle atrophy is associated with up-regulation of USP-19 via p38 and ERK MAPKs. J Cell Biochem 2011; in press.
7. Pitta F, Troosters T, Spruit MA, et al. Characteristics ofphysical activities in daily life in chronic obstructive pulmonarydisease. Am J Respir Crit Care Med 2005; 171(9):972-977. (Pubitemid 40616945)
8. Watz H, Waschki B, Meyer T, et al. Physical activity in patientswith COPD. Eur Respir J 2009; 33(2):262-272.
9. Choi I, Lee K, Kim M, et al. Diff erential activation of stressresponsivesignalling proteins associated with altered loadingin a rat skeletal muscle. J Cell Biochem 2005; 96(6):1231-1243. (Pubitemid 41681865)
10. Childs TE, Spangenburg EE, Vyas DR, et al. Temporal alterations in protein signaling cascades during recovery from muscle atrophy. Am J Physiol Cell Physiol 2003; 285(2):C391-98. (Pubitemid 36917854)
11. Morris RT, Spangenburg EE, Booth FW. Responsiveness of cell signaling pathways during the failed 15-day regrowth of aged skeletal muscle. J Appl Physiol 2004; 96(1):398-404. (Pubitemid 38032026)
12. Machida S, Booth FW. Changes in signalling molecule levels in 10-day hindlimb immobilized rat muscles. Acta Physiol Scand 2005; 183(2):171-179. (Pubitemid 40203610)
13. Li YP, Chen Y, John J, et al. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 2005; 19(3):362-370. (Pubitemid 40316524)
14. Obata T, Brown GE, Yaff e MB. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med 2000; 28(4 Suppl):N67-77. (Pubitemid 30262049)
15. Barreiro E, Gea J, Corominas JM, et al. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003; 29(6):771-778. (Pubitemid 38045945)
16. Barreiro E, Schols AM, Polkey MI, et al. Cytokine profi le in quadriceps muscles of patients with severe COPD. Thorax 2008; 63(2):100-107. (Pubitemid 351236469)
17. Powers SK, Kavazis AN, McClung JM. Oxidative stress and disuse muscle atrophy. J Appl Physiol 2007; 102(6):2389-2397. (Pubitemid 47080773)
18. Lemire BB, Debigaré R, Theriault M, et al. MAPK Signaling In The quadriceps of patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2011; 183:A2527.
19. Kent LM, Smyth LJ, Plumb J, et al. Inhibition of lipopolysaccharide- stimulated chronic obstructive pulmonary disease macrophage infl ammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difl uorophenyl)-4-(4-fl uoro- 2-methylphenyl)-7-oxo-7 ,8-dihydropyrido[2,3-d] pyrimidin- 2-yl]amino}ethyl) guanidine (SB706504). J Pharmacol Exp Ther 2009; 328(2):458-468.
20. Montalban AG, Boman E, Chang CD, et al. KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. Eur J Pharmacol 2010; 632(1-3):93-102.
21. Singh D, Smyth L, Borrill Z, et al. A randomized, placebocontrolled study of the Effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of infl ammation in COPD patients. J Clin Pharmacol 2010; 50(1):94-100.
22. Medicherla S, Fitzgerald MF, Spicer D, et al. p38alphaselective mitogen-activated protein kinase inhibitor SD-282 reduces infl ammation in a subchronic model of tobacco smoke-induced airway infl ammation. J Pharmacol Exp Ther 2008; 324(3):921-929. (Pubitemid 351397845)
23. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176(6):532-555. (Pubitemid 47403272)
24. Steiner MC, Barton RL, Singh SJ, et al. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002; 19(4):626-631. (Pubitemid 34285158)
25. Edwards RHT, Young A, Hosking GP, et al. Human skeletal muscle function: description of tests and normal values. Clin Sci 1977; 52:283-290. (Pubitemid 8071796)
26. Polkey MI, Kyroussis D, Hamnegard C-H, et al. Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve 1996; 19:549-555. (Pubitemid 26120162)
27. Bergstrom L. Muscle electrolytes in man. Determination by neutron activation analysis on needle biopsy specimens. A study on normal subjects, kidney patients, and patients with chronic diarrhea. Scand J Clin Lab Invest 1962; 68:1-110.
28. Franssen FM, Broekhuizen R, Janssen PP, et al. Limb muscle dysfunction in COPD: Effects of muscle wasting and exercise training. Med Sci Sports Exerc 2005; 37(1):2-9. (Pubitemid 40076008)
29. Cote CG, Casanova C, Marin JM, et al. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 2008; 31(3):571-578.
30. Spruit MA, Polkey MI, Celli B, et al. Predicting Outcomes from 6-Minute Walk Distance in Chronic Obstructive Pulmonary Disease. J Amer Med Direct Asso 2011; in press.
31. Chen S, Qiong Y, Gardner DG. A role for p38 mitogenactivated protein kinase and c-myc in endothelin-dependent rat aortic smooth muscle cell proliferation. Hypertension 2006; 47(2):252-258. (Pubitemid 43189771)
32. Weiss C, Faust D, Durk H, et al. TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPKdependent pathway. Oncogene 2005; 24(31):4975-4983. (Pubitemid 41129101)
33. Marinissen MJ, Chiariello M, Gutkind JS. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev 2001; 15(5):535-553. (Pubitemid 32205143)
34. Sarkar D, Su ZZ, Lebedeva IV, et al. mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci USA 2002; 99(15):10054-10059. (Pubitemid 34831171)
35. Di GioVanni S, Molon A, Broccolini A, et al. Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 2004; 55(2):195-206. (Pubitemid 38166996)
36. Swallow EB, Barreiro E, Gosker H, et al. Quadriceps muscle strength in scoliosis. Eur Respir J 2009; 34(6):1429-1435
37. Wretman C, Widegren U, Lionikas A, et al. Diff erential activation of mitogen-activated protein kinase signaling pathways by isometric contractions in isolated slow- and fast-twitch rat skeletal muscle. Acta Physiol Scand 2000; 170(1):45-49.
38. Mylabathula DB, Rice KM, Wang Z, et al. Age-associated changes in MAPK activation in fast- and slow-twitch skeletal muscle of the F344/NNiaHSD X Brown Norway/BiNia rat model. Exp Gerontol 2006; 41(2):205-214. (Pubitemid 43165693)
39. Gosker H, Zeegers M, Wouters E, et al. Muscle fi bre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 2007; 62(11):944-9. (Pubitemid 350084491)
40. Adachi T, Kikuchi N, Yasuda K, et al. Fibre type distribution and gene expression levels of both succinate dehydrogenase and peroxisome proliferator-activated receptor-gamma coactivator-1alpha of fi bres in the soleus muscle of Zucker diabetic fatty rats. Exp Physiol 2007; 92(2):449-455. (Pubitemid 46376319)
41. Gosselink JV, Hayashi S, Elliott WM, et al. Diff erential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181(12):1329-1335.
42. Hamnegard CH, Sedler M, Polkey MI, et al. Quadriceps strength assessed by magnetic stimulation of the femoral nerve in normal subjects. Clin Physiol Funct Imag 2004; 24(5):276-280. (Pubitemid 39359397)
43. Csukly KJ, Martineau LC, Gardiner PF. Inter- and intramuscle comparisons of MAPK mechanosensitivity: evidence for the absence of fi bre-type dependency. Pfl ugers Arch 2002; 444(6):732-737. (Pubitemid 35204020)
44. Jiang F, Li P, Fornace AJ, Jr., et al. G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J Biol Chem 2003; 278(48):48030-48040. (Pubitemid 37523253)
45. Buitrago CG, Ronda AC, de Boland AR, et al. MAP kinases p38 and JNK are activated by the steroid hormone 1alpha,25(OH)2- vitamin D3 in the C2C12 muscle cell line. J Cell Biochem 2006; 97(4):698-708.
46. Janssens W, Bouillon R, Claes B, et al. Vitamin D defi ciency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010; 65(3):215-220.
47. Hopkinson NS, Li KW, Kehoe A, et al. Vitamin D receptor genotypes infl uence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr 2008; 87(2):385-390. (Pubitemid 351226075)
48. Spruit MA, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003; 58(9):752-756. (Pubitemid 37094049)
49. Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest 2006; 129(3):536-544.
50. Austin RL, Rune A, Bouzakri K, et al. siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle. Diabetes 2008;57(8):2066-2073.
51. Crul T, Spruit MA, Gayan-Ramirez G, et al. Markers of infl ammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest 2007; 37(11):897-904. (Pubitemid 350029204)
52. Seymour JM, Ward K, Sidhu P, et al. Ultrasound measurement of rectus femoris cross-sectional area and the relationship to quadriceps strength in chronic obstructive pulmonary disease. Thorax 2009; 64:418-423.
53. Doucet M, Russell AP, Leger B, et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructivepulmonary disease. Am J Respir Crit Care Med 2007;176(3):261-269. (Pubitemid 47195876)